| Literature DB >> 28658208 |
Esther Rheinbay1,2, Prasanna Parasuraman2, Jonna Grimsby1, Grace Tiao1, Jesse M Engreitz1,3, Jaegil Kim1, Michael S Lawrence1,2, Amaro Taylor-Weiner1, Sergio Rodriguez-Cuevas4, Mara Rosenberg1, Julian Hess1, Chip Stewart1, Yosef E Maruvka1,2, Petar Stojanov1, Maria L Cortes1, Sara Seepo1, Carrie Cibulskis1, Adam Tracy1, Trevor J Pugh5, Jesse Lee2, Zongli Zheng2, Leif W Ellisen2,6, A John Iafrate2, Jesse S Boehm1, Stacey B Gabriel1, Matthew Meyerson1,6,7, Todd R Golub1,6,7, Jose Baselga8, Alfredo Hidalgo-Miranda9, Toshi Shioda2, Andre Bernards2, Eric S Lander1, Gad Getz1,2,6,10.
Abstract
Genomic analysis of tumours has led to the identification of hundreds of cancer genes on the basis of the presence of mutations in protein-coding regions. By contrast, much less is known about cancer-causing mutations in non-coding regions. Here we perform deep sequencing in 360 primary breast cancers and develop computational methods to identify significantly mutated promoters. Clear signals are found in the promoters of three genes. FOXA1, a known driver of hormone-receptor positive breast cancer, harbours a mutational hotspot in its promoter leading to overexpression through increased E2F binding. RMRP and NEAT1, two non-coding RNA genes, carry mutations that affect protein binding to their promoters and alter expression levels. Our study shows that promoter regions harbour recurrent mutations in cancer with functional consequences and that the mutations occur at similar frequencies as in coding regions. Power analyses indicate that more such regions remain to be discovered through deep sequencing of adequately sized cohorts of patients.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28658208 PMCID: PMC5563978 DOI: 10.1038/nature22992
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962